Dr. Christopher Joseph Abularrage, MD

Dr. Abularrage practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Abularrage's NPI, 1063675908, was assigned on July 9, 2008. Dr. Abularrage graduated from Georgetown University School Of Medicine in 2001. Dr. Abularrage holds Maryland license D70352.

Dr. Abularrage's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Abularrage's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Abularrage is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Abularrage to 1 more hospital and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abularrage practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Abularrage's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Abularrage is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Abularrage's licenses on file in 5 states: Maryland, Massachusetts, Florida, District of Columbia and Virginia.

Dmand AI lists amputation, arterial blot clot /embolism, carotid revascularization, heart device and aorta surgery, leg revascularization and removal of damaged skin or skin graft among the conditions Dr. Abularrage treats.

CMS data shows 646 Medicare services from Dr. Abularrage across 12 procedure codes in 2024, for 284 Medicare patients. Medicare paid $56,802 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 284 Medicare patients who saw Dr. Abularrage in 2024. The largest group is 65 to 74, with 126 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 3.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abularrage's median patient age at 73, with 38% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Abularrage for performance year 2024, reported as part of a group. CMS counts 38 procedures of leg revascularization (restoring blood flow) by Dr. Abularrage, more than 92% of the clinicians it reports for that procedure.

Dmand AI links 166 papers to Dr. Abularrage, published from 2006 to 2025. 2017 was the busiest year, with 12. The most frequent topics are Endovascular Procedures, Peripheral Arterial Disease and Diabetic Foot. Dr. Abularrage has published most often in J Vasc Surg. Dr. Abularrage's most frequent co-authors are Caitlin Whitney Hicks, MD, MS, James Hamilton Black, MD and Mahmoud Malas, MD.

CMS Open Payments shows 46 general payments to Dr. Abularrage from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 68% of the total. Medtronic, Inc. paid the most, $6,566.

Dmand AI lists 3 awards for Dr. Abularrage, most recently Distinguished Fellow in 2018.

Dr. Abularrage graduated from Georgetown University School Of Medicine in 2001. Dr. Abularrage is a member of ACS and SVS.

Dr. Abularrage is in network with 9 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.